Stockreport

Novo Nordisk: Oral Weight-Loss To The Rescue [Seeking Alpha]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF NVO's oral Wegovy pill demonstrated superior weight-loss efficacy versus Eli Lilly's orforglipron, with 16.6% mean loss and 34.4% of patients exceeding 20% weight loss. [Read more]